Teva Loses Appeal Over Four Patents for MS Drug Copaxone

Bookmark
(Bloomberg) -- Teva Pharmaceutical Industries Ltd. lost an appeals court bid to revive four U.S. patents on its top-selling multiple sclerosis drug Copaxone.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.